Clostridium difficile infection associated with antituberculous agents in a patient with tuberculous pericarditis

9Citations
Citations of this article
26Readers
Mendeley users who have this article in their library.

Abstract

Clostridium difficile can cause pseudomembranous colitis (PMC). Antimicrobial agent exposure is a risk factor for Clostridium difficile-associated disease, whereas the use of antituberculous (anti-TB) agents is not. We herein report a case of PMC-associated with antituberculous therapy. A 63-year-old woman with tuberculous pericarditis treated with anti-TB agents was admitted for abdominal pain and diarrhea. On colonoscopy, mucoid exudate and yellowish plaque lesions were observed. The anti-TB agents were discontinued, and the patient was treated with metronidazole and clostridium butyricum. Her symptoms were relieved and did not recur when the anti-TB agents were restarted. In this report, we review the literature and discuss the pathogenesis, clinical manifestations, diagnosis and treatment of this case. © 2013 The Japanese Society of Internal Medicine.

Cite

CITATION STYLE

APA

Sun, Y. X., Zhao, Y. T., Teng, L. L., Ge, J. L., Jiang, H., & Shao, L. (2013). Clostridium difficile infection associated with antituberculous agents in a patient with tuberculous pericarditis. Internal Medicine. https://doi.org/10.2169/internalmedicine.52.0162

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free